MUMBAI -- Reliance Life Sciences Pvt. Ltd has introduced six anti-cancer drug brands in India, including a generic version of Swiss drugmaker Novartis AG's anti-blood cancer drug Glivec, as it seeks to tap the fast-growing market for oncology drugs in the country.
Read more: http://medcitynews.com/2013/09/reliance-life-sciences-taps-cancer-drug-market-india/#ixzz2fnylGOub
